MedTrace Logo

Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules

NCT06381557 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2024-04-24

No results posted yet for this study

Summary

Traditional Chinese medicine（TCM） has achieved some meaningful results in improving the symptoms and quality of life of cancer patients, but many research results need to be further verified by clinical trials with larger samples and better design.This study aims to investigate effectiveness and safety of Zhengyuan Capsules for cancer-related fatigue in patients with breast cancer.

Conditions

  • Cancer-related Fatigue

Interventions

DRUG

Zhengyuan Capsules

Zhengyuan capsules, 4 capsules at a time, 3 times per day;

DRUG

Placebo contains 5%-10% Zhengyuan Capsule total mixed powder

Zhengyuan capsules simulator（Placebo contains 5%-10% Zhengyuan Capsule total mixed powder）, 4 capsules at a time, 3 times per day;

Sponsors & Collaborators

  • Yangtze River Pharmaceutical Group Co., Ltd.

    collaborator INDUSTRY

  • Qiang Fu

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2027-03-01
Completion
2027-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06381557 on ClinicalTrials.gov